Skip to content

Long-Term Effects of Whole-Body Vibration on Sarcopenia in Geriatric Population

Comparison of long-term effects of active range of motion exercises with and without whole-body vibration on skeletal muscle index and physical performance in elderly population with sarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230304057612N1
Enrollment
56
Registered
2023-04-26
Start date
2023-05-21
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia.

Interventions

Intervention 1: Intervention group: It will contain subgroups of an equal number of males and females. This group will receive 10 bouts of WBV with frequency progressively increasing from 15 to 40 Hz

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Elderly aged 60 years and above Participants who meet sarcopenia diagnostic criteria based on the EWGSOP2 algorithm for case-finding and diagnosis with Skeletal Muscle Index (SMI) <7.0 kg/m2 and <5.5 kg/m2 for males and females, respectively Negative Romberg's sign Participants who are willing to comply with the study protocol and give informed consent in writing

Exclusion criteria

Exclusion criteria: Participants who meet “severe” sarcopenia diagnostic criteria based on the EWGSOP2 algorithm for case-finding and diagnosis with a score of =8 on Short Physical Performance Battery (SPPB) Presence of any neuromuscular, autoimmune, or infectious diseases Participants with Total Hip Replacement, Total Knee Replacement and any other lower limb implants Participants unable to flex the knee joints to 90° or having pain in their knees or ankles due to any problem such as arthritic changes Participants with any critical cognitive (Mini–Mental State Examination, MMSE score?<?23) or physical dysfunctions that may interfere with the test or training procedures Participants with cardiovascular and/or pulmonary diseases, which can get aggravated after exercise Participants who are taking drugs that can affect the neuromuscular system Participants who are osteoporotic with T-score < -2.5 on DEXA at the lumbar spine/ femoral neck/distal third of the radius

Design outcomes

Primary

MeasureTime frame
Fall risk. Timepoint: before intervention, after intervention and 8 weeks post termination of intervention. Method of measurement: Falls Efficacy Scale-International which is a short, easy to administer tool that measures level of concern about falling during social and physical activities inside and outside the home whether or not the person usually does the activity. The level of concern is measured on a four-point Likert scale (1=not at all concerned to 4=very concerned) with score of 16 denoting no concern about falling while score of 64 denotes severe concern about falling.;Skeletal Muscle Index (SMI). Timepoint: before intervention, after intervention and 8 weeks post termination of intervention. Method of measurement: Dual-energy X-ray absorptiometry (DEXA) will be carried out for each participant by the same technician. All assessments will be performed at the same time in the day around 10 a.m. to 12 noon.;Muscle strength. Timepoint: before intervention, after intervention and 8 weeks post termination of intervention. Method of measurement: Dynamometer for the hand grip strength and knee strength will be used. For measuring hand grip strength, participant will be asked to squeeze the handle of dynamometer as strongly as possible while three readings will be noted in kilograms from the alternate hand to relax the other hand. After three trials, the highest value of the 3 repetitions will be considered for each hand separately. For measuring maximal isometric strength of knee extensors, the participants will be instructed to sit with their hips and knees at 90 degrees flexion, legs perpendicular to the floor and the feet not touching the ground. The dynamometer will be placed just proximal to the ankle on the front leg. A high density foam pad may be placed between the dynamometer's force pad and the subjects' leg for comfort and to protect subjects' skin. During testing, the subjects will be instructed to contract maximally and to sustain the maximal volunt

Secondary

MeasureTime frame
Quality of life. Timepoint: before intervention, after intervention and 8 weeks post termination of intervention. Method of measurement: SarQoL questionnaire which is a self-administered questionnaire comprising of 55 items and 22 questions and is organized into 7 domains of health related quality of life (QOL) including Physical and Mental Health, Locomotion, Body composition, Functionality, Activities of daily living, Leisure activities and Fears. Each domain is scored from 0 (worst QOL) to 100 (best QOL) and overall score is calculated.;Inflammatory markers. Timepoint: before intervention, after intervention and 8 weeks post termination of intervention. Method of measurement: Plasma levels will be assessed for each participant in the pathologic lab through blood sample obtained from antecubital vein between 8 a.m. to 10 a.m.

Countries

Pakistan

Contacts

Public ContactShafaq Altaf

Tehran University of Medical Sciences

shafaq.altaf.shah@gmail.com+92 343 5020507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026